Development, Feasibility, and Efficacy of a Web-Based Intervention to Reduce Psychological Barriers to Insulin Therapy among Adults with Type 2 Diabetes (Stage 2: Pilot Study)
- Conditions
- Type 2 diabetesInsulin therapyMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12619001382167
- Lead Sponsor
- The Australian Centre for Behavioural Research in Diabetes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 35
Each participant must meet all of the following criteria, as self-reported, to be enrolled in this study:
- Aged 18 to 75 years at the time of randomisation
- Self-reported diagnosis of T2D
- Currently using oral hypoglycaemic agents for the treatment of T2D
- Able to read/write in English and capable of understanding the informed consent document and provide consent
- Residing in Australia at the time of randomisation and throughout the study period
- Access to an internet-enabled device (i.e. computer, tablet) for the duration of the study.
Potential participants meeting any of the following criteria will be excluded from the study:
- Self-reported diagnosis of diabetes other than T2D (e.g. Type 1, gestational, LADA)
- Current (or in the past) use of an injectable medication (i.e. GLP-1 agonist, insulin) at the time of randomisation
- Prior experience of self-administered injectable treatment for any illness or condition
- Unable to read/write in English
- Unable to use/access internet-enabled devices (i.e. computer, tablet) during the study period
- Reports being very willing” to initiate insulin therapy (measured using a single-item hypothetical willingness” questionnaire), i.e. rendering it impossible to record improvement in this outcome measure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method